OSBORNE DAVID W

Track

Insider profile

OSBORNE DAVID W's trades of Arcutis Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
497.06
Quantity 62,374
Value US$4,655,166
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-04 2024-03-04
PrS Proposed sale
62,374
497.06
US$4,655,166 		62,374 497.06 US$4,655,166
2023-03-08 2023-03-06
PlS Planned sale
85,720 -37.6%
21.58
US$4,378,903 		85,720 -37.6% 21.58 US$4,378,903
2023-03-02 2023-03-02
PlS Planned sale
74,150 -13.6%
283.08
US$1,786,343 		74,150 -13.6% 283.08 US$1,786,343
2023-03-02 2023-03-02
PlS Planned sale
1,198 -0.5%
15.82
US$18,951 		1,198 -0.5% 15.82 US$18,951
2023-03-02 2023-02-28
PlS Planned sale
792 -0.3%
16.17
US$12,804 		792 -0.3% 16.17 US$12,804
2022-07-12 2022-07-08
PlS Planned sale
2,197 -0.8%
25.41
US$55,835 		2,197 -0.8% 25.41 US$55,835
2022-04-21 2022-04-21
PlS Planned sale
2,197 -0.8%
20.42
US$44,872 		2,197 -0.8% 20.42 US$44,872
2022-03-07 2022-03-07
PlS Planned sale
28 -0.0%
16.44
US$460 		28 -0.0% 16.44 US$460
2022-03-07 2022-03-04
PlS Planned sale
828 -0.3%
16.86
US$13,959 		828 -0.3% 16.86 US$13,959
2022-03-03 2022-03-01
PlS Planned sale
775 -0.3%
17.75
US$13,758 		775 -0.3% 17.75 US$13,758
2021-03-03 2021-03-01
PlS Planned sale
780 -0.3%
34.57
US$26,968 		780 -0.3% 34.57 US$26,968
2020-12-16 2020-12-14
PlS Planned sale
15,000 -5.6%
30.00
US$450,000 		15,000 -5.6% 30.00 US$450,000
2020-10-01 2020-09-29
PlS Planned sale
15,000 -5.4%
30.00
US$450,000 		15,000 -5.4% 30.00 US$450,000